1.The company was invited to attend the 11th Global Hunan Business Conference

On September 12, the 11th Global Hunan Business Conference was hosted by the CPC Hunan Provincial Committee and Hunan Provincial People's Government at Huaihua International Convention and Exhibition Center. The event was led by Su Dehui, Deputy Party Secretary, Vice Chairman and General Manager of Hunan Pharmaceutical Development Investment Group, with Shen Fanshun, Party Branch Secretary and Chairman of the company, attending as his companion.

Shen Fanshun attended the "Medical and Health Industry Development Exchange Conference and Huaihua Conference on Traditional Chinese Medicine ISO International Standards". He visited Huairan Health Industry Group, Zhengqing Pharmaceutical Group, Hunan Pharmaceutical Group Huaihua Company, Huaihua Zhengjiao Pharmaceutical and other enterprises, and discussed potential cooperation opportunities with relevant enterprises.

Shen Fanshun also exchanged views with Wu Hanming, Secretary of the Party Committee of Huitong County, and Zhang Guanghui, Secretary of the Party Committee of the First Affiliated Hospital of Hunan Medical University, on deepening cooperation in traditional Chinese medicinal materials and company products.

The company will leverage this conference to strengthen partnerships with Huaihua Municipal Government, medical institutions, and pharmaceutical enterprises. It will intensify its long-term procurement of premium Chinese medicinal materials in Huaihua, accelerate the promotion and application of its products in the region, and simultaneously advance the ISO certification process for its related products.

2.Company's participation in 2024 International (Bozhou) Traditional Chinese Medicine Expo

From September 9 to 12, Kang Yongfeng, Deputy General Manager of the company, and the Regional Manager of its subsidiary Suoyuan Chinese Medicinal Materials Company attended the 2024 International (Bozhou) Traditional Chinese Medicine Expo and the 40th National (Bozhou) Chinese Medicinal Materials Trade Fair.

The current Pharmaceutical Expo was jointly organized by the China Traditional Chinese Medicine Association, China Food Industry Association, China Chamber of Commerce for Import and Export of Medicines and Health Products, China Medicinal Food Research Association, and other organizations, with Bozhou Culture and Tourism Group as the main organizer, attracting over a thousand enterprises to participate. At the exhibition, Kang Yongfeng engaged in in-depth exchanges with outstanding peer enterprises on the cultivation, processing, and management of Chinese medicinal materials, reaching cooperation intentions and promoting the implementation of the "going global" and "bringing in" strategies of Traceable Chinese Medicinal Materials Company. In the next step, Traceable Chinese Medicinal Materials Company will further strengthen external exchanges and cooperation in the business of Chinese medicinal materials, based in Hunan, expanding nationwide, improving the industrial chain layout, and striving to become stronger, bigger, and better in the Chinese medicinal materials industry.

3.The company was invited to attend the Biotechnology Forum and Exhibition in Hong Kong

From September 10 to 12, the company was invited to BIOHK2024 Hong Kong International Biotechnology Forum and Exhibition. The event was led by Mo Zhong, Deputy General Manager and Party Committee Member of Hunan Pharmaceutical Development Investment Group Co., Ltd., with Hu Xiujuan, Director of the Marketing Center, and Cai Meifen, Director of the Strategic Development Department, accompanying the company to the exhibition.

The Hong Kong International Biotechnology Forum and Exhibition is the highest-specification and largest-scale professional exhibition in Hong Kong's biotechnology industry. This exhibition will build an international cooperation, exchange, and innovation platform for China's biotechnology industry, leveraging Hong Kong's geographical advantages to promote the convergence of innovative resources, assist corporate growth and the overseas expansion of Chinese enterprises, and jointly drive the high-quality development of China's biotechnology industry. Through this exchange visit, it will facilitate cooperation between companies and Hong Kong and Macao.